Preparation and Evaluation of Dual Targeting Nanoparticles for Oral Cancer
来源期刊:Journal Of Wuhan University Of Technology Materials Science Edition2019年第6期
论文作者:吴珊珊 XIONG Fuliang ZHANG Xueqiong QIU Tong TANG Mingxiu YE Xiaojing 陈芷筠 周刚
文章页码:1495 - 1504
摘 要:A dual-receptor targeting delivery system based on acid-cleavage hydrazone bond was developed in the study. The characters of CMCS-hyd-CUR-EGFR-mAb were identified. The in vitro release studies revealed that this drug delivery system was acid-sensitive, and the self-assembled nanoparticles which were spherical. The in vitro results indicated that the dual-receptor targeting nanoparticles could be faster internalized into the Cal-27 cells via receptor-mediated endocytosis, which exhibited better antitumor activity than the one-receptor nanoparticles. The experimental results clearly reveal that CMCS-hyd-CUR-EGFR mAb provides a novel way for drug delivery in oral cancer treatment.
吴珊珊1,XIONG Fuliang1,ZHANG Xueqiong1,QIU Tong2,TANG Mingxiu1,YE Xiaojing3,陈芷筠4,周刚5
1. Department of Phamaceutical Engineering, School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology2. Biomedical Materials and Engineering Center, Wuhan University of Technology3. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University4. Department of stomatology, Maternal and Child Health Hospital of Hubei Province5. Department of Oral Medicine, School and Hospital of Stomatology, Wuhan University
摘 要:A dual-receptor targeting delivery system based on acid-cleavage hydrazone bond was developed in the study. The characters of CMCS-hyd-CUR-EGFR-mAb were identified. The in vitro release studies revealed that this drug delivery system was acid-sensitive, and the self-assembled nanoparticles which were spherical. The in vitro results indicated that the dual-receptor targeting nanoparticles could be faster internalized into the Cal-27 cells via receptor-mediated endocytosis, which exhibited better antitumor activity than the one-receptor nanoparticles. The experimental results clearly reveal that CMCS-hyd-CUR-EGFR mAb provides a novel way for drug delivery in oral cancer treatment.
关键词: